MACROGENICS INC - Common Stock (MGNX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
MGNX on Nasdaq
Shares outstanding
62,912,484
Price per share
$1.61
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
45,995,618
Total reported value
$77,272,120
% of total 13F portfolios
0%
Share change
-2,289,555
Value change
-$2,545,327
Number of holders
101
Price from insider filings
$1.61
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MACROGENICS INC - Common Stock (MGNX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% -0.1% $6,925,600 +$22,000 6,296,000 +0.32% Armistice Capital, LLC 31 Mar 2025
WASATCH ADVISORS LP 3.1% -42% $3,276,482 -$2,584,186 1,950,287 -44% Wasatch Advisors LP 30 Sep 2025
BlackRock, Inc. 2.9% $2,793,090 1,813,695 BlackRock, Inc. 30 Jun 2025
MILLENNIUM MANAGEMENT LLC 2.7% $1,896,675 1,724,250 Millennium Management LLC 31 Mar 2025
Frazier Life Sciences Public Fund, L.P. 2.5% $2,230,838 1,549,193 Frazier Life Sciences Public Fund, L.P. 30 Jun 2025

As of 30 Sep 2025, 101 institutional investors reported holding 45,995,618 shares of MACROGENICS INC - Common Stock (MGNX). This represents 73% of the company’s total 62,912,484 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of MACROGENICS INC - Common Stock (MGNX) together control 67% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bellevue Group AG 16% 9,919,992 0% 0.35% $16,665,587
ARMISTICE CAPITAL, LLC 9.5% 5,960,000 0% 0.31% $10,012,800
VANGUARD GROUP INC 6.7% 4,224,234 +0.26% 0% $7,096,714
Frazier Life Sciences Management, L.P. 5% 3,175,665 0% 0.16% $5,335,117
ACADIAN ASSET MANAGEMENT LLC 4% 2,517,547 +1% 0.01% $4,224,000
MILLENNIUM MANAGEMENT LLC 3.4% 2,116,870 +5% 0% $3,556,342
WASATCH ADVISORS LP 3.1% 1,950,287 -40% 0.02% $3,276,482
RENAISSANCE TECHNOLOGIES LLC 2.7% 1,701,223 +28% 0% $2,858,055
BlackRock, Inc. 2.4% 1,538,694 -15% 0% $2,585,006
MORGAN STANLEY 1.6% 989,233 +122% 0% $1,661,912
JANE STREET GROUP, LLC 1.3% 846,694 +12% 0% $1,422,446
JACOBS LEVY EQUITY MANAGEMENT, INC 1.3% 815,865 -19% 0.01% $1,370,653
JPMORGAN CHASE & CO 1.2% 755,245 +64% 0% $1,268,812
TWO SIGMA ADVISERS, LP 1.2% 748,600 -13% 0% $1,257,648
Connor, Clark & Lunn Investment Management Ltd. 1.1% 710,608 +4.2% 0% $1,193,821
GEODE CAPITAL MANAGEMENT, LLC 1% 657,521 -3.8% 0% $1,105,085
MARSHALL WACE, LLP 1% 629,535 +55% 0% $1,057,619
CITADEL ADVISORS LLC 0.78% 493,531 +188% 0% $829,132
TWO SIGMA INVESTMENTS, LP 0.69% 437,091 +7.3% 0% $734,313
MACQUARIE GROUP LTD 0.67% 420,000 0% 0% $706,000
Squarepoint Ops LLC 0.61% 385,633 +595% 0% $647,863
DIMENSIONAL FUND ADVISORS LP 0.55% 345,582 -32% 0% $580,863
PINNACLE ASSOCIATES LTD 0.54% 338,106 -3.7% 0.01% $568,018
Voleon Capital Management LP 0.49% 307,395 0.01% $516,424
Vestal Point Capital, LP 0.45% 280,000 0% 0.02% $470,400

Institutional Holders of MACROGENICS INC - Common Stock (MGNX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 8,273 $14,119 -$49,985 $1.61 3
2025 Q3 45,995,618 $77,272,120 -$2,545,327 $1.68 101
2025 Q2 48,254,634 $58,417,269 -$6,816,345 $1.21 109
2025 Q1 53,787,262 $68,275,566 -$6,563,219 $1.27 124
2024 Q4 56,087,049 $182,279,127 +$1,568,950 $3.25 125
2024 Q3 54,902,225 $180,609,419 -$21,599,477 $3.29 121
2024 Q2 60,788,311 $258,348,037 -$142,489,931 $4.25 141
2024 Q1 64,741,585 $952,995,859 +$51,470,754 $14.72 159
2023 Q4 69,384 $667,474 +$167,811 $9.62 3
2023 Q3 58,037,379 $270,452,147 -$10,613,706 $4.66 124
2023 Q2 60,016,268 $321,082,876 +$4,896,662 $5.35 128
2023 Q1 58,447,529 $419,063,254 +$13,087,885 $7.17 134
2022 Q4 56,606,520 $379,815,649 +$1,094,443 $6.71 129
2022 Q3 51,364,028 $177,713,090 -$23,378,733 $3.46 120
2022 Q2 56,768,099 $167,655,988 -$39,952,038 $2.95 118
2022 Q1 59,433,783 $523,601,517 +$330,812 $8.81 132
2021 Q4 56,845,458 $912,446,686 -$26,536,114 $16.05 144
2021 Q3 57,060,841 $1,194,847,781 +$1,536,010 $20.94 146
2021 Q2 56,371,706 $1,514,168,329 -$11,443,385 $26.86 144
2021 Q1 55,993,827 $1,783,387,052 +$102,994,705 $31.85 167
2020 Q4 52,861,586 $1,208,340,258 -$8,137,913 $22.86 138
2020 Q3 51,819,742 $1,305,354,085 +$54,356,797 $25.19 131
2020 Q2 49,810,738 $1,390,736,624 +$298,793,891 $27.92 128
2020 Q1 35,942,407 $209,163,821 -$14,099,919 $5.82 109
2019 Q4 45,276,441 $492,595,348 -$13,652,023 $10.88 120
2019 Q3 46,405,435 $592,119,161 -$12,374,353 $12.76 117
2019 Q2 46,885,111 $795,527,771 +$190,256,302 $16.97 126
2019 Q1 43,987,790 $790,851,758 +$149,792,811 $17.98 150
2018 Q4 36,692,691 $465,980,099 -$27,600,828 $12.70 121
2018 Q3 36,789,217 $788,932,455 -$33,998,670 $21.44 126
2018 Q2 38,406,868 $793,108,768 +$10,000,005 $20.65 124
2018 Q1 37,718,690 $948,900,306 +$109,925,179 $25.16 129
2017 Q4 33,613,899 $638,065,847 +$15,121,484 $19.00 114
2017 Q3 31,534,713 $582,287,305 +$4,949,691 $18.48 110
2017 Q2 31,163,751 $545,715,268 +$34,365,823 $17.51 110
2017 Q1 28,839,774 $536,477,176 +$36,844,051 $18.60 109
2016 Q4 29,057,417 $593,900,489 -$13,781,655 $20.44 126
2016 Q3 28,100,900 $840,483,283 +$4,825,834 $29.91 127
2016 Q2 28,106,896 $758,599,766 +$13,469,100 $26.99 118
2016 Q1 27,894,848 $522,939,644 +$3,760,834 $18.75 123
2015 Q4 27,594,292 $854,618,717 +$11,794,286 $30.97 126
2015 Q3 27,119,223 $580,875,686 +$99,856,523 $21.42 119
2015 Q2 21,501,458 $816,403,412 +$77,701,220 $37.97 123
2015 Q1 19,750,659 $620,034,002 +$92,794,585 $31.37 108
2014 Q4 16,800,712 $589,208,584 +$46,498,533 $35.07 105
2014 Q3 15,387,666 $321,606,508 +$2,191,816 $20.90 81
2014 Q2 15,286,023 $332,162,989 +$24,086,854 $21.73 87
2014 Q1 12,494,296 $347,628,815 +$111,521,845 $27.83 73